NoileImmune Biotech Inc (4893)

Currency in JPY
139.00
+1.00(+0.72%)
Closed·
Earnings results expected in 5 days
4893 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
135.00139.00
52 wk Range
114.00217.00
Key Statistics
Bid/Ask
137.00 / 139.00
Prev. Close
138
Open
138
Day's Range
135-139
52 wk Range
114-217
Volume
64.7K
Average Volume (3m)
151.6K
1-Year Change
-19.6532%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
4893 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
440.00
Upside
+216.55%
Members' Sentiments
Bearish
Bullish
ProTips
Analysts anticipate sales growth in the current year

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Buy
Moving Averages
Strong Buy

Analyst Ratings

1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 440.00
(+216.55% Upside)

Earnings

Latest Release
May 14, 2026
EPS / Forecast
-3.54 / --
Revenue / Forecast
2M / --
EPS Revisions
Last 90 days

4893 Income Statement

Compare 4893 to Peers and Sector

Metrics to compare
4893
Peers
Sector
Relationship
P/E Ratio
−8.5x−9.0x−0.4x
PEG Ratio
−0.47−0.310.00
Price/Book
1.6x2.9x2.6x
Price / LTM Sales
2,010.8x20.5x3.0x
Upside (Analyst Target)
216.5%118.6%50.7%
Fair Value Upside
Unlock5.6%7.2%Unlock

Noile-Immune Biotech Inc. researches and develops CAR-T cells for novel cancer immunotherapies. The company’s product pipeline includes, NIB101, a target antigen for solid tumors; NIB102, a next-generation CAR-T cell therapy; NIB103, autologous CAR-T cell therapy for mesothelin (MSLN); NIB104, a PRIME technology against target antigens in solid tumors; ADAP01; AUTL01; and CHUG01. Noile-Immune Biotech Inc. was incorporated in 2015 and is headquartered in Minato, Japan.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
47.80K0.11%6.64M
Other Institutional Investors
10.82M24.93%1.50B
Public Companies & Retail Investors
32.53M74.96%4.52B
Total
43.4M100.00%6.03B

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Takeda Ventures, Inc.18.71%8,119,8001,128,652
Daiwa Taiwan-Japan Biotech Fund Investment Limited Partnership3.11%1,349,200187,539

FAQ

What Is the NoileImmune Biotech (4893) Stock Price Today?

The NoileImmune Biotech stock price today is 139.00 JPY.

What Stock Exchange Does NoileImmune Biotech Trade On?

NoileImmune Biotech is listed and trades on the Tokyo Stock Exchange.

What Is the Stock Symbol for NoileImmune Biotech?

The stock symbol for NoileImmune Biotech is "4893."

What Is the NoileImmune Biotech Market Cap?

As of today, NoileImmune Biotech market cap is 6.03B JPY.

What Is NoileImmune Biotech's Earnings Per Share (TTM)?

The NoileImmune Biotech EPS (TTM) is -16.30.

When Is the Next NoileImmune Biotech Earnings Date?

NoileImmune Biotech will release its next earnings report on Aug 13, 2026.

From a Technical Analysis Perspective, Is 4893 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has NoileImmune Biotech Stock Split?

NoileImmune Biotech has split 0 times.

How Many Employees Does NoileImmune Biotech Have?

NoileImmune Biotech has 23 employees.

What is the current trading status of NoileImmune Biotech (4893)?

As of Aug 08, 2026, NoileImmune Biotech (4893) is trading at a price of 139.00 JPY, with a previous close of 138.00 JPY. The stock has fluctuated within a day range of 135.00 JPY to 139.00 JPY, while its 52-week range spans from 114.00 JPY to 217.00 JPY.

What Is NoileImmune Biotech (4893) Price Target According to Analysts?

The average 12-month price target for NoileImmune Biotech is 440.00 JPY, with a high estimate of 440 JPY and a low estimate of 440 JPY. 1 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +216.55% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.